Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: A cohort study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Golledge, Jonathan ^a,b   Quigley, Frank ^b   Velu, Ramesh ^b   Walker, Phillip J ^c,d   Moxon, Joseph V ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Diabetes; Mortality; Patient management; Peripheral artery disease; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANEURYSM; AORTA ANEURYSM; ARTICLE; CAROTID ARTERY OBSTRUCTION; COHORT ANALYSIS; CRITICAL LIMB ISCHEMIA; DYSGLYCEMIA; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; SMOKING; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; MIDDLE AGED; PHYSIOLOGY; PREDIABETIC STATE; RISK FACTOR; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREDIABETIC STATE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84920829926     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0147-2     Document Type: Article

References (38)

1. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T, ESC Committee for Practice Guidelines: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011, 32(22):2851-2906.
2. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA, Prevention of Atherothrombotic Disease Network: Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003, 163(8):884-892.
3. Haigh KJ, Bingley J, Golledge J, Walker PJ: Barriers to screening and diagnosis of peripheral artery disease by general practitioners. Vasc Med 2013, 18(6):325-330.
4. Federation ID: IDF Diabetes Atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2013.
5. Tapp RJ, Balkau B, Shaw JE, Valensi P, Cailleau M, Eschwege E: Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis 2007, 190(1):84-89.
6. Norman PE, Davis TM, Le MT, Golledge J: Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res 2007, 48(3):125-131.
7. Vonbank A, Saely CH, Rein P, Drexel H: Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. Cardiovasc Diabetol 2013, 12:106.
8. Papa G, Degano C, Iurato MP, Licciardello C, Maiorana R, Finocchiaro C: Macrovascular complication phenotypes in type 2 diabetic patients. Cardiovasc Diabetol 2013, 12:20.
9. Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B: Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 2014, 59(5):1291-1299.
10. Kamalesh M, Shen J: Diabetes and peripheral arterial disease in men: trends in prevalence, mortality, and effect of concomitant coronary disease. Clin Cardiol 2009, 32(8):442-446.
11. Suzuki K, Iida O, Yamauchi Y, Nakano M, Soga Y, Kawasaki D, Tazaki J, Yamaoka T, Suematsu N, Shintani Y, Miyashita Y, Inoue N, Meguro T: Impact of diabetes mellitus on critical limb ischemia with below the knee disease: Japan below-the-knee artery treatment subanalysis. Angiologia 2013, In press.
12. Abularrage CJ, Conrad MF, Hackney LA, Paruchuri V, Crawford RS, Kwolek CJ, LaMuraglia GM, Cambria RP: Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg 2010, 52(2):314-22.e1-314-22.e4.
13. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, Belkin M, Conte MS: Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg 2007, 45(5):944-952.
14. Green FC, Levison R, Newton DJ, Littleford R, Stonebridge PA, Belch JJ: Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease. Int Angiol 2012, 31(2):125-128.
15. Golledge J, Cronin O, Iyer V, Bradshaw B, Moxon JV, Cunningham MA: Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis 2013, 229(2):549-555.
16. Golledge J, Ewels C, Muller R, Walker PJ: Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease. Atherosclerosis 2014, 232(2):289-297.
17. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49(12):1373-1379.
18. Moxon JV, Liu D, Wong G, Weir JM, Behl-Gilhotra R, Bradshaw B, Kingwell BA, Meikle PJ, Golledge J: Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circ Cardiovasc Genet 2014, 7:71-79.
19. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26(11):3160-3167.
20. Shaw JE, Zimmet PZ, Alberti KG: Point: impaired fasting glucose: the case for the new American Diabetes Association criterion. Diabetes Care 2006, 29(5):1170-1172.
21. Camafort M, Alvarez-Rodriguez LR, Munoz-Torrero JF, Sahuquillo JC, Lopez-Jimenez L, Coll R, Monreal M: Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry. Diabet Med 2011, 28(1):73-80.
22. Zhang Y, Hu G, Yuan Z, Chen L: Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One 2012, 7(8):e42551.
23. Singh S, Armstrong EJ, Sherif W, Alvandi B, Westin GG, Singh GD, Amsterdam EA, Laird JR: Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty. Vasc Med 2014, 19(4):307-314.
24. Khalil H, Tan L, George J: Diabetes management in Australian rural aged care facilities: a cross-sectional audit. Aust Med J 2012, 5(11):575-580.
25. Ibrahim NK, Attia SG, Sallam SA, Fetohy EM, El-Sewi F: Physicians' therapeutic practice and compliance of diabetic patients attending rural primary health care units in Alexandria. J Fam Comm Med 2010, 17(3):121-128.
26. Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC Jr, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators: Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010, 170(21):1892-1899.
27. Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA: Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail 2013, 6(3):395-402.
28. Hajjar J, Habra MA, Naing A: Metformin: an old drug with new potential. Exp Opin Invest Drugs 2013, 22(12):1511-1517.
29. Dosluoglu HH, Lall P, Nader ND, Harris LM, Dryjski ML: Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia. J Vasc Surg 2010, 51(5):1178-1189.
30. Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, Elasy TA, Griffin MR: Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA 2014, 311(22):2288-2296.
31. Hall GC, McMahon AD, Carroll D, Home PD: Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study. Pharmacoepidemiol Drug Saf 2012, 21(3):305-313.
32. Hallberg V, Palomaki A, Lahtela J, Voutilainen S, Tarkka M, Kataja M: Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG. Cardiovasc Diabetol 2014, 13:25.
33. Terry T, Raravikar K, Chokrungvaranon N, Reaven PD: Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep 2012, 14(1):79-88.
34. Ghasemi A, Zahediasl S, Azizi F: Reference values for fasting serum glucose levels in healthy Iranian adult subjects. Clin Lab 2011, 57(5-6):343-349.
35. Rosa BL, Vicenta LC, Victor GC, Dolores LC, Fernando C, Ricardo GH, Lina B, Tinahones FJ: Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes. Cardiovasc Diabetol 2012, 11:86.
36. Buysschaert M, Bergman M: Definition of prediabetes. Med Clin North Am 2011, 95(2):289-297.
37. Hjellestad ID, Astor MC, Nilsen RM, Softeland E, Jonung T: HbA (1) c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc Diabetol 2013, 12:79.
38. Brouwer BG, Visseren FL, Algra A, van Bockel JH, Bollen EL, Doevendans PA, Greving JP, Kappelle LJ, Moll FL, Pijl H, Romijn JA, van der Wall EE, van der Graaf Y: Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study. J Intern Med 2010, 268(1):83-93.